Klaus-Peter Koller

Title: Klaus-Peter Koller: Innovator in Enzyme Catalysis and Cell Regulation

Introduction

Klaus-Peter Koller is a notable inventor based in Bad Soden, Germany. He has made significant contributions to the fields of enzyme catalysis and cell regulation, holding a total of 9 patents. His work has implications in various scientific and medical applications.

Latest Patents

One of his latest patents is titled "Process for delaying the deactivation of glutaryl amidase during enzyme catalysis." This invention relates to a method that prolongs the activity of glutaryl amidase, allowing it to be reused in subsequent reaction batches. The process involves separating the enzyme catalyst after maximum substrate conversion and delaying its inactivation by introducing a thiol during the reaction. Another significant patent is for the "Cell regulation factor TTO 20." This invention encompasses the DNA coding for TTO 20, its preparation, and its use in diagnostic kits for detecting inflammatory disorders, particularly rheumatoid arthritis.

Career Highlights

Throughout his career, Klaus-Peter Koller has worked with prominent companies such as Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His experience in these organizations has contributed to his expertise in the field of biochemistry and enzyme technology.

Collaborations

Klaus-Peter Koller has collaborated with notable colleagues, including Johannes Meiwes and Gunther J. Riess. These partnerships have likely enhanced his research and development efforts in his areas of expertise.

Conclusion

Klaus-Peter Koller is a distinguished inventor whose work in enzyme catalysis and cell regulation has led to valuable patents and advancements in medical diagnostics. His contributions continue to impact the scientific community positively.